Sunday, 5th September 2010
Encapsulation and barrier technologies patent filings see explosive growth since 2000
03 September 2010

The commercialisation of OLED technology is driving the growth of sealing, barrier and encapsulation technologies, and more than 90% of the patents since according to the latest Encapsulation and barriers: A review of the patent landscape from cintelliq Limited, a leading provider of information services and technology consulting to the organic semiconductor and organic electronics industries.

 

Figure 1: Encapsulation and barrier technology accumulated patent growth 1998-2009
Read more...
 
Idemitsu Kosan acquires stake in LG Group OLED patent business
07 June 2010

Idemitsu Kosan Co has announced that the company has acquired a 32.73% stake in Global OLED Technology LLC, the LG Group company that acquired all of the Kodak patents back in Dec 2009 . It has been estimated that Idemitsu paid several billion yen for this stake. According to reports Global OLED Technology owns about 2,000 patents related to OLED technology. This stake continues to build on the relationship Idemitsu and LG Display Co. formed last year to develop OLED technologies to make large area OLED displays that have extended lifetimes.

Idemitsu has been keen to diversify by seeking to strengthen its non-petroleum operations by expanding in the electronic materials segment. Investing in Global OLED Technology will help Idemitsu tap the intellectual property and strengthen cooperation with the LG group in developing and supplying electronic components. Idemitsu aims to generate 6.5 billion yen in sales of electronic materials in fiscal 2012, up 180% from fiscal 2009.

www.idemitsu.co.jp     www.lgdisplay.com

 
QD Vision acquires Motorola quantum dot patent portfolio
27 May 2010

QD Vision has announced the company has purchased from Motorola a patent portfolio pertaining to the use of quantum dot technology in display and lighting products.

Included in the acquisition is U.S. Patent No. 5,442,254 of Jaskie, one of the earliest patents on the use of photoluminescent quantum dots in product applications, and pending applications relating to the use of quantum dots to a wide variety of display applications, including LCD backlight units.

Prior to this acquisition, QD Vision’s position in quantum dot intellectual property already included nine issued patents and more than 130 patents pending originating at MIT and QD Vision.

Read more...
 
H.C. Starck Clevios and Agfa-Gevaert resolve outstanding intellectual property dispute
12 April 2010

H.C. Starck Clevios GmbH, the world’s leading supplier of conductive polymers, is pleased to announce the establishment of a cross-licensing agreement with Agfa-Gevaert N.V., Mortsel, Belgium. This agreement resolves outstanding intellectual property disputes between the parties.

The agreement which covers PEDOT:PSS materials and formulations, provides a firm footing for the delivery of product and technological know-how to a number of industries including printed electronics, electroluminescence, touch screens and new technologies. By removing the uncertainty surrounding the intellectual property, the agreement will facilitate product development by both the companies and their customers.

The settlement is of particular and lasting interest as it relates to a number of patents, effective until beyond 2020, which will enable emerging technologies to be based on PEDOT:PSS.

According to the announcement this agreement justifies ongoing high investment in R&D, now unhindered by the rights of the other party.

For both Agfa-Gevaert N.V. and H.C. Starck Clevios GmbH the first steps into the technology of the electro conductive polymer PEDOT:PSS dates from when both companies were owned by Bayer AG. Bayer AG originally developed the material in 1988 and its first application was an antistatic in Agfa’s photographic film. For over 10 years the material has been marketed under the trade name of Orgacon™ from Agfa-Gevaert N.V. and Clevios™ (formerly Baytron) from H.C. Starck Clevios GmbH.

Dr. Aloys Eiling, CEO of H.C. Starck Clevios GmbH, said, “The settlement of intellectual property disputes between Agfa and H.C. Starck will ensure access to this cutting edge technology and allow the accelerated application of PEDOT:PSS into emerging technologies such as printed electronics.”

www.hcstarck.com     www.agfa.com

 
Cambrios Technologies licences processing IP from University of Washington
08 February 2010

Cambrios Technologies Corp. has announced that they have licensed intellectual property covering commercially relevant methods of manufacturing metal nanostructures from the University of Washington. The patent US 7,585,349. assigned to the University of Washington and covering an invention made by Younan Xia and Yougang Sun has been licensed exclusively to Cambrios in its specific field of use.

Read more...
 
Unidym completes licensing of carbon nanotube IP
25 January 2010

Unidym, Inc has announced that it has completed three licensing agreements for its nanotechnology intellectual property (IP) for use in applications such as aerospace and military products. Each license agreement provides for modest upfront fees and future royalty payments to Unidym.

Read more...
 
Arrowhead Research sells Tego Bioscience IP portfolio to Luna Innovations
04 January 2010

Arrowhead Research Corp has recently announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property (IP) to Luna Innovations, Inc., a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines. Under the terms of the agreement, Luna paid Tego $430,000 upfront, will make milestone payments totalling $4.25 million for each fullerene product it brings to market under Tego IP, and pay royalties on net sales of its products built with the Tego IP.

Read more...
 
Bayer MaterialScience and Add-Vision sign licence agreement
15 June 2009

Bayer MaterialScience AG signed a technology and patent license agreement with Add-Vision Inc. The agreement grants Bayer MaterialScience and its affiliates certain rights to manufacture and sell flexible polymer organic light-emitting diode (P-OLED) displays using Add-Vision's technology and intellectual property (IP) portfolio.

Read more...
 


Free Subscription

To receive your own personal free copy of OSA Direct every week
sign up here